ID   AMHR2_HUMAN             Reviewed;         573 AA.
AC   Q16671; A0AVE1; B9EGB7; E9PGD2; F8W1D2; Q13762; Q647K2;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   10-MAY-2017, entry version 175.
DE   RecName: Full=Anti-Muellerian hormone type-2 receptor;
DE            EC=2.7.11.30;
DE   AltName: Full=Anti-Muellerian hormone type II receptor;
DE            Short=AMH type II receptor;
DE   AltName: Full=MIS type II receptor;
DE            Short=MISRII;
DE            Short=MRII;
DE   Flags: Precursor;
GN   Name=AMHR2; Synonyms=AMHR, MISR2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7493017; DOI=10.1038/ng1295-382;
RA   Imbeaud S., Faure E., Lamarre I., Mattei M.-G., di Clemente N.,
RA   Tizard R., Carre-Eusebe D., Belville C., Tragethon L., Tonkin C.,
RA   Nelson J., McAuliffe M., Bidart J.-M., Lababidi A., Josso N.,
RA   Cate R.L., Picard J.-Y.;
RT   "Insensitivity to anti-Muellerian hormone due to a mutation in the
RT   human anti-Muellerian hormone receptor.";
RL   Nat. Genet. 11:382-388(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7488027; DOI=10.1006/bbrc.1995.2567;
RA   Visser J.A., McLuskey A., van Beers T., Weghuis D.O., van Kessel A.G.,
RA   Grootegoed J.A., Themmen A.P.N.;
RT   "Structure and chromosomal localization of the human anti-Muellerian
RT   hormone type II receptor gene.";
RL   Biochem. Biophys. Res. Commun. 215:1029-1036(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=10589763;
RA   Masiakos P.T., MacLaughlin D.T., Maheswaran S., Teixeira J.,
RA   Fuller A.F. Jr., Shah P.C., Kehas D.J., Kenneally M.K.,
RA   Dombkowski D.M., Ha T.U., Preffer F.I., Donahoe P.K.;
RT   "Human ovarian cancer, cell lines, and primary ascites cells express
RT   the human Muellerian inhibiting substance (MIS) type II receptor,
RT   bind, and are responsive to MIS.";
RL   Clin. Cancer Res. 5:3488-3499(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND VARIANT HIS-319.
RA   Li H., Ke R., Shen C., Zhou G., Zhong G., Lin L., Yang S.;
RL   Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   VARIANTS PMDS2 CYS-54; VAL-142; GLN-282; GLY-426; 445-GLY--LEU-453
RP   DEL; ALA-458; HIS-491 AND CYS-504.
RX   PubMed=8872466; DOI=10.1093/hmg/5.9.1269;
RA   Imbeaud S., Belville C., Messika-Zeitoun L., Rey R., di Clemente N.,
RA   Josso N., Picard J.-Y.;
RT   "A 27 base-pair deletion of the anti-Muellerian type II receptor gene
RT   is the most common cause of the persistent Muellerian duct syndrome.";
RL   Hum. Mol. Genet. 5:1269-1277(1996).
RN   [9]
RP   VARIANT PMDS2 GLN-406.
RX   PubMed=11549681; DOI=10.1210/jcem.86.9.7839;
RA   Messika-Zeitoun L., Gouedard L., Belville C., Dutertre M., Lins L.,
RA   Imbeaud S., Hughes I.A., Picard J.-Y., Josso N., di Clemente N.;
RT   "Autosomal recessive segregation of a truncating mutation of anti-
RT   Muellerian type II receptor in a family affected by the persistent
RT   Muellerian duct syndrome contrasts with its dominant negative activity
RT   in vitro.";
RL   J. Clin. Endocrinol. Metab. 86:4390-4397(2001).
CC   -!- FUNCTION: On ligand binding, forms a receptor complex consisting
CC       of two type II and two type I transmembrane serine/threonine
CC       kinases. Type II receptors phosphorylate and activate type I
CC       receptors which autophosphorylate, then bind and activate SMAD
CC       transcriptional regulators. Receptor for anti-Muellerian hormone.
CC   -!- CATALYTIC ACTIVITY: ATP + [receptor-protein] = ADP + [receptor-
CC       protein] phosphate.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- INTERACTION:
CC       P08238:HSP90AB1; NbExp=2; IntAct=EBI-6423788, EBI-352572;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q16671-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q16671-2; Sequence=VSP_044548;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q16671-3; Sequence=VSP_045281;
CC   -!- DISEASE: Persistent Muellerian duct syndrome 2 (PMDS2)
CC       [MIM:261550]: A form of male pseudohermaphroditism characterized
CC       by a failure of Muellerian duct regression in otherwise normal
CC       males. {ECO:0000269|PubMed:11549681, ECO:0000269|PubMed:8872466}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. TGFB receptor subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Anti-Mullerian hormone entry;
CC       URL="https://en.wikipedia.org/wiki/Anti-m%C3%BCllerian_hormone";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X89013; CAA61418.1; -; Genomic_DNA.
DR   EMBL; U29700; AAC50328.1; -; Genomic_DNA.
DR   EMBL; X91156; CAA62593.1; -; Genomic_DNA.
DR   EMBL; X91157; CAA62593.1; JOINED; Genomic_DNA.
DR   EMBL; X91158; CAA62593.1; JOINED; Genomic_DNA.
DR   EMBL; X91159; CAA62593.1; JOINED; Genomic_DNA.
DR   EMBL; X91160; CAA62593.1; JOINED; Genomic_DNA.
DR   EMBL; X91161; CAA62593.1; JOINED; Genomic_DNA.
DR   EMBL; X91162; CAA62593.1; JOINED; Genomic_DNA.
DR   EMBL; X91163; CAA62593.1; JOINED; Genomic_DNA.
DR   EMBL; X91164; CAA62593.1; JOINED; Genomic_DNA.
DR   EMBL; X91165; CAA62593.1; JOINED; Genomic_DNA.
DR   EMBL; X91166; CAA62593.1; JOINED; Genomic_DNA.
DR   EMBL; AF172932; AAD48497.1; -; mRNA.
DR   EMBL; AY714878; AAU21221.1; -; mRNA.
DR   EMBL; AK313593; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC068889; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC126316; AAI26317.1; -; mRNA.
DR   EMBL; BC136356; AAI36357.1; -; mRNA.
DR   CCDS; CCDS53798.1; -. [Q16671-3]
DR   CCDS; CCDS55829.1; -. [Q16671-2]
DR   CCDS; CCDS8858.1; -. [Q16671-1]
DR   PIR; JC4335; JC4335.
DR   RefSeq; NP_001158162.1; NM_001164690.2. [Q16671-2]
DR   RefSeq; NP_001158163.1; NM_001164691.2. [Q16671-3]
DR   RefSeq; NP_065434.1; NM_020547.3. [Q16671-1]
DR   UniGene; Hs.659889; -.
DR   ProteinModelPortal; Q16671; -.
DR   SMR; Q16671; -.
DR   BioGrid; 106766; 2.
DR   IntAct; Q16671; 4.
DR   STRING; 9606.ENSP00000257863; -.
DR   DrugBank; DB00171; Adenosine triphosphate.
DR   iPTMnet; Q16671; -.
DR   PhosphoSitePlus; Q16671; -.
DR   BioMuta; AMHR2; -.
DR   DMDM; 9087133; -.
DR   PaxDb; Q16671; -.
DR   PeptideAtlas; Q16671; -.
DR   PRIDE; Q16671; -.
DR   DNASU; 269; -.
DR   Ensembl; ENST00000257863; ENSP00000257863; ENSG00000135409. [Q16671-1]
DR   Ensembl; ENST00000379791; ENSP00000369117; ENSG00000135409. [Q16671-3]
DR   Ensembl; ENST00000550311; ENSP00000446661; ENSG00000135409. [Q16671-2]
DR   GeneID; 269; -.
DR   KEGG; hsa:269; -.
DR   UCSC; uc001scx.2; human. [Q16671-1]
DR   CTD; 269; -.
DR   DisGeNET; 269; -.
DR   GeneCards; AMHR2; -.
DR   HGNC; HGNC:465; AMHR2.
DR   HPA; HPA060228; -.
DR   HPA; HPA069636; -.
DR   MalaCards; AMHR2; -.
DR   MIM; 261550; phenotype.
DR   MIM; 600956; gene.
DR   neXtProt; NX_Q16671; -.
DR   OpenTargets; ENSG00000135409; -.
DR   Orphanet; 2856; Persistent Mullerian duct syndrome.
DR   PharmGKB; PA24770; -.
DR   eggNOG; KOG3653; Eukaryota.
DR   eggNOG; ENOG410XS2Z; LUCA.
DR   GeneTree; ENSGT00860000133897; -.
DR   HOGENOM; HOG000033920; -.
DR   HOVERGEN; HBG097461; -.
DR   InParanoid; Q16671; -.
DR   KO; K04672; -.
DR   OMA; CNANYSH; -.
DR   OrthoDB; EOG091G05X7; -.
DR   PhylomeDB; Q16671; -.
DR   TreeFam; TF314724; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   SignaLink; Q16671; -.
DR   SIGNOR; Q16671; -.
DR   GenomeRNAi; 269; -.
DR   PRO; PR:Q16671; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000135409; -.
DR   CleanEx; HS_AMHR2; -.
DR   ExpressionAtlas; Q16671; baseline and differential.
DR   Genevisible; Q16671; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:Ensembl.
DR   GO; GO:1990272; F:anti-Mullerian hormone receptor activity; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042562; F:hormone binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004872; F:receptor activity; IMP:UniProtKB.
DR   GO; GO:0004702; F:signal transducer, downstream of receptor, with serine/threonine kinase activity; IEA:InterPro.
DR   GO; GO:0005026; F:transforming growth factor beta receptor activity, type II; IEA:Ensembl.
DR   GO; GO:0008585; P:female gonad development; IEA:Ensembl.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:0001880; P:Mullerian duct regression; NAS:UniProtKB.
DR   GO; GO:1902613; P:negative regulation of anti-Mullerian hormone signaling pathway; IEA:Ensembl.
DR   GO; GO:0007548; P:sex differentiation; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IMP:UniProtKB.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:Ensembl.
DR   InterPro; IPR000472; Activin_recp.
DR   InterPro; IPR015771; Anti-muellerian_hrmn_rcpt_II.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR000333; TGFB_receptor.
DR   PANTHER; PTHR23255; PTHR23255; 1.
DR   Pfam; PF01064; Activin_recp; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF037392; AMHRII; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome;
KW   Disease mutation; Disulfide bond; Glycoprotein; Kinase; Magnesium;
KW   Manganese; Membrane; Metal-binding; Nucleotide-binding; Polymorphism;
KW   Pseudohermaphroditism; Receptor; Reference proteome;
KW   Serine/threonine-protein kinase; Signal; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     17       {ECO:0000255}.
FT   CHAIN        18    573       Anti-Muellerian hormone type-2 receptor.
FT                                /FTId=PRO_0000024408.
FT   TOPO_DOM     18    149       Extracellular. {ECO:0000255}.
FT   TRANSMEM    150    170       Helical. {ECO:0000255}.
FT   TOPO_DOM    171    573       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      203    518       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     209    217       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    333    333       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   BINDING     230    230       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   CARBOHYD     66     66       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    119    119       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     55     79       {ECO:0000250|UniProtKB:P37023}.
FT   DISULFID     92    109       {ECO:0000250|UniProtKB:P37023}.
FT   VAR_SEQ     381    475       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_045281.
FT   VAR_SEQ     430    573       DSSPPPFQLAYEAELGNTPTSDELWALAVQERRRPYIPSTW
FT                                RCFATDPDGLRELLEDCWDADPEARLTAECVQQRLAALAHP
FT                                QESHPFPESCPRGCPPLCPEDCTSIPAPTILPCRPQRSACH
FT                                FSVQQGPCSRNPQPACTLSPV -> AVHHPSNWPMRQNWAI
FT                                PLPLMSYGPWQCRRGGVPTSHPPGAALPQTLMG (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044548.
FT   VARIANT      54     54       R -> C (in PMDS2; dbSNP:rs534999427).
FT                                {ECO:0000269|PubMed:8872466}.
FT                                /FTId=VAR_015525.
FT   VARIANT     142    142       G -> V (in PMDS2).
FT                                {ECO:0000269|PubMed:8872466}.
FT                                /FTId=VAR_015526.
FT   VARIANT     282    282       H -> Q (in PMDS2; dbSNP:rs539695176).
FT                                {ECO:0000269|PubMed:8872466}.
FT                                /FTId=VAR_015527.
FT   VARIANT     319    319       R -> H (in dbSNP:rs144236183).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_069048.
FT   VARIANT     406    406       R -> Q (in PMDS2; dbSNP:rs137853104).
FT                                {ECO:0000269|PubMed:11549681}.
FT                                /FTId=VAR_015528.
FT   VARIANT     426    426       D -> G (in PMDS2).
FT                                {ECO:0000269|PubMed:8872466}.
FT                                /FTId=VAR_015529.
FT   VARIANT     445    453       Missing (in PMDS2).
FT                                {ECO:0000269|PubMed:8872466}.
FT                                /FTId=VAR_031057.
FT   VARIANT     458    458       V -> A (in PMDS2; dbSNP:rs775889926).
FT                                {ECO:0000269|PubMed:8872466}.
FT                                /FTId=VAR_015530.
FT   VARIANT     491    491       D -> H (in PMDS2; dbSNP:rs780680518).
FT                                {ECO:0000269|PubMed:8872466}.
FT                                /FTId=VAR_015531.
FT   VARIANT     504    504       R -> C (in PMDS2; dbSNP:rs772294564).
FT                                {ECO:0000269|PubMed:8872466}.
FT                                /FTId=VAR_015532.
FT   CONFLICT    121    121       S -> N (in Ref. 4; AAU21221).
FT                                {ECO:0000305}.
FT   CONFLICT    161    161       L -> V (in Ref. 2; CAA62593).
FT                                {ECO:0000305}.
FT   CONFLICT    501    501       V -> A (in Ref. 4; AAU21221).
FT                                {ECO:0000305}.
SQ   SEQUENCE   573 AA;  62750 MW;  1347C10C2942FDBA CRC64;
     MLGSLGLWAL LPTAVEAPPN RRTCVFFEAP GVRGSTKTLG ELLDTGTELP RAIRCLYSRC
     CFGIWNLTQD RAQVEMQGCR DSDEPGCESL HCDPSPRAHP SPGSTLFTCS CGTDFCNANY
     SHLPPPGSPG TPGSQGPQAA PGESIWMALV LLGLFLLLLL LLGSIILALL QRKNYRVRGE
     PVPEPRPDSG RDWSVELQEL PELCFSQVIR EGGHAVVWAG QLQGKLVAIK AFPPRSVAQF
     QAERALYELP GLQHDHIVRF ITASRGGPGR LLSGPLLVLE LHPKGSLCHY LTQYTSDWGS
     SLRMALSLAQ GLAFLHEERW QNGQYKPGIA HRDLSSQNVL IREDGSCAIG DLGLALVLPG
     LTQPPAWTPT QPQGPAAIME AGTQRYMAPE LLDKTLDLQD WGMALRRADI YSLALLLWEI
     LSRCPDLRPD SSPPPFQLAY EAELGNTPTS DELWALAVQE RRRPYIPSTW RCFATDPDGL
     RELLEDCWDA DPEARLTAEC VQQRLAALAH PQESHPFPES CPRGCPPLCP EDCTSIPAPT
     ILPCRPQRSA CHFSVQQGPC SRNPQPACTL SPV
//
